text: <unk>  is an antitubercular drug that is FDA approved for the treatment of pulmonary tuberculosis, in combination with other antituberculosis agents, as second-line therapy. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include drug-induced eosinophilia, Ototoxicity, raised serum blood urea nitrogen.
option_0: Capreomycin sulfate
option_1: Paromomycin sulfate
option_2: Silver sulfadiazine
option_3: Lincomycin Hydrochloride
option_4: Oxytetracycline hydrochloride
option_5: Diloxanide furoate
option_6: Amikacin sulfate
option_7: Clindamycin phosphate 